DREAM-HF trial results highlight Mesoblast’s potential to differentiate in HF space: GlobalData EP News Bureau Dec 19, 2024 Revascor shows potential in reducing cardiovascular mortality and improving outcomes in high-risk heart failure patients, marking…
AUM Biosciences announces closing of $27 million in a “Series A” round of funding EP News Bureau Oct 13, 2021 This round was led by Singapore-based Everlife and SPRIM Global investments (SGI)
IQVIA announces JAPAC expansion of IQVIA Biotech EP News Bureau May 25, 2021 Since its launch, IQVIA Biotech has initiated hundreds of new trials for biotech companies, including COVID-19 trials
